Summary of at‐home ocrelizumab infusion procedures
The majority of patients received acetaminophen (94.9%), methylprednisolone (89.9%) and diphenhydramine (88.9%) prior to their ocrelizumab infusion (Table Infusion procedure by study cohort.One patient switched to 25 mg of diphenhydramine due to a prior reaction with the 50‐mg dose.Longer infusion times may have been a result of mechanical and other interruptions.